IRVINE, CA, May 31, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it will present at the first MPS World Summit to be held in New Orleans this week from May 31st to June 3rd, 2022.
Dr. Steve George, co-founder of Aracari, will present on the Microphysiological Systems for Immune Cell Trafficking and Capture. Dr. Chris Hughes, Chief Scientific Officer and also a co-founder of Aracari, will present on the Validation of an MPS Human Tumor Model. Mr. Will Bralower, Research Associate of Aracari, will co-present at the Educational Workshop on Lessons Learned: Engineering MPS Platforms as a Physiologist. In addition, the Aracari team members will be available at booth #121 in the exhibitor hall.
Event: MPS World Summit
Date: Tuesday, May 31st, 2022
Time and Session: 9:00 AM – 11:45 AM Educational Workshop. 1. Lessons Learned: Engineering MPS Platforms as a Physiologist
By Jenn Fang, Tulane University and Will Bralower, Aracari Biosciences
2:15 PM S2.2,12. Microphysiological Systems for Immune Cell Trafficking and Capture
By Steve George, Aracari Biosciences and UC Davis
3:40 PM S2.3, 276. Validation of an MPS Human Tumor Model: Vascularized Colon Cancer Microtumors Recapitulate In Vivo Drug Responses
By Chris Hughes, Aracari Biosciences and UC Irvine
About Aracari Biosciences, Inc.
Aracari’s mission is to accelerate drug development and tailor treatments to individual patients by using the greater accuracy of its microphysiological platforms to predict drug reactions in humans. Aracari’s 3D Vascularized Micro-Organ and Micro-Tumor platforms incorporate living, perfused human vasculature to deliver nutrients, drugs and immune cells into the microenvironment of multiple tissue and tumor types, just as they are delivered in the human body. Aracari’s powerful next-generation tools already are advancing discovery in immuno-oncology therapies and drug development.